A 3-D echo exam using the GE Vivid E95 ultrasound system at the American Society of Echocardiography (ASE) 2018. For more on the system watch this VIDEO

 

Heart Rhythm Society (HRS)

Society for Cardiovascular Angiography and Interventions (SCAI)

Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.

Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia.[1]  There are several reasons why learning more about the optimal management of such patients must be a key priority for both cardiac and non-cardiac specialties in the current era:
 

A 360 degree view of the true 3D imaging workstation from EchoPixel. The image of the aortic valve on screen appears as double vision because the operator needs 3D glasses to rectify the image (See operator by rotating the image). The green lines on the right side of the screen is are from a handheld pointer that is used to grab the image to slice through the image dataset and rotate the image (see pointer in his hand).

General Manager, GE Healthcare Cardiovascular Ultrasound

Heart disease is globally pervasive and it is not going away. It’s the leading cause of death around the world, and the cause of one-third of all deaths in the United States.[1] That’s why the ability to detect cardiac complications early – with monitoring and medical imaging – represents a critical step in the future of improved patient outcomes.  

A 360 degree view of a booth demonstration of the Philips Healthcare Epiq cardiovascular ultrasound system at the American Society of Echocardiography (ASE) 2018 meeting in June. On the screen can be seen a demonstration of the system's new 3-D lighting software, where the light source can be moved around to increase contrast by shadowing.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now